MX360235B - Composicion para evitar o tratar osteoporosis y metodo de manufactura para el mismo. - Google Patents
Composicion para evitar o tratar osteoporosis y metodo de manufactura para el mismo.Info
- Publication number
- MX360235B MX360235B MX2012014402A MX2012014402A MX360235B MX 360235 B MX360235 B MX 360235B MX 2012014402 A MX2012014402 A MX 2012014402A MX 2012014402 A MX2012014402 A MX 2012014402A MX 360235 B MX360235 B MX 360235B
- Authority
- MX
- Mexico
- Prior art keywords
- preventing
- composition
- treating osteoporosis
- manufacturing
- method therefor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una composición para prevenir o tratar osteoporosis que comprende un ácido ibandronico, o una sal farmacéuticamente aceptable del mismo, o un hidrato del mismo y la vitamina D. La presente invención se refiere a una composición para prevenir o tratar osteoporosis que tiene efectos medicinales uniformes reduciendo al mínimo las diferencias en propiedades físicas entre ácido ibandrónico o la sal farmacéuticamente aceptable del mismo, o el hidrato del mismo y vitamina D.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100054921A KR101230178B1 (ko) | 2010-06-10 | 2010-06-10 | 골다공증 예방 또는 치료용 조성물 및 이의 제조방법 |
PCT/KR2011/004067 WO2011155728A2 (ko) | 2010-06-10 | 2011-06-03 | 골다공증 예방 또는 치료용 조성물 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012014402A MX2012014402A (es) | 2013-02-01 |
MX360235B true MX360235B (es) | 2018-10-26 |
Family
ID=45098503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012014402A MX360235B (es) | 2010-06-10 | 2011-06-03 | Composicion para evitar o tratar osteoporosis y metodo de manufactura para el mismo. |
Country Status (9)
Country | Link |
---|---|
US (1) | US9044401B2 (es) |
EP (1) | EP2581086A4 (es) |
JP (1) | JP5756172B2 (es) |
KR (1) | KR101230178B1 (es) |
CN (1) | CN102946884B (es) |
BR (1) | BR112012030485A2 (es) |
CA (1) | CA2798368C (es) |
MX (1) | MX360235B (es) |
WO (1) | WO2011155728A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101102364B1 (ko) * | 2009-09-18 | 2012-01-03 | 한림제약(주) | 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물 |
PT106978A (pt) * | 2013-05-31 | 2014-12-02 | Tecnimede Sociedade Tecnico Medicinal S A | Composição sólida oral contendo ácido ibandrónico e vitamina d |
CN107206011B (zh) * | 2015-01-28 | 2020-10-20 | 韩美药品株式会社 | 包括雷洛昔芬以及维生素d或其衍生物的复合胶囊 |
KR101774690B1 (ko) * | 2016-04-22 | 2017-09-05 | 알보젠코리아 주식회사 | 라록시펜과 비타민 d를 포함하는 복합제제 |
KR102136459B1 (ko) * | 2018-06-08 | 2020-07-21 | 알보젠코리아 주식회사 | 바제독시펜과 비타민 d를 포함하는 복합제제 |
KR20210086463A (ko) | 2019-12-30 | 2021-07-08 | 경북대학교 산학협력단 | 4-헥실레소르시놀을 유효성분으로 포함하는 골질환 예방 또는 치료용 약학조성물 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0998933A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
AU2003226148A1 (en) * | 2002-04-05 | 2003-10-27 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
US20040097468A1 (en) | 2002-11-20 | 2004-05-20 | Wimalawansa Sunil J. | Method of treating osteoporosis and other bone disorders with upfront loading of bisphosphonates, and kits for such treatment |
US7511028B2 (en) * | 2003-08-29 | 2009-03-31 | Brookler Kenneth H | Use of bisphosphonates for otosclerosis |
WO2005117906A1 (en) | 2004-05-19 | 2005-12-15 | Merck & Co., Inc. | Combination for inhibiting bone resorption comprising a bisphosponate (alendrona) and a vitamin d (cholecalciferol) |
KR20050110814A (ko) * | 2004-05-19 | 2005-11-24 | 머크 앤드 캄파니 인코포레이티드 | 골 흡수를 억제하기 위한 조성물 및 방법 |
US20050261250A1 (en) * | 2004-05-19 | 2005-11-24 | Merck & Co., Inc., | Compositions and methods for inhibiting bone resorption |
CN1729950A (zh) * | 2004-08-05 | 2006-02-08 | 龙桦兴业有限公司 | 具有生理检测功能的卫生用品及其检测方法 |
GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
WO2008026907A1 (es) | 2006-08-29 | 2008-03-06 | Espinosa Abdala Leopoldo De Je | Composición farmacéutica que comprende ibandronato y vitamina d3 para el tratamiento de osteoporosis |
WO2008074144A1 (en) | 2006-12-20 | 2008-06-26 | Genpharm Ulc | A composition containing a bisphosphonic acid in combination with vitamin d |
CN201200626Y (zh) * | 2008-06-17 | 2009-03-04 | 黑龙江福和华星制药集团股份有限公司 | 一种含有二膦酸盐类片和维生素d片的片剂胶囊 |
KR101102364B1 (ko) * | 2009-09-18 | 2012-01-03 | 한림제약(주) | 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물 |
CN102958513A (zh) | 2010-07-06 | 2013-03-06 | 株式会社那笔制药 | 含达泊西汀的延时释放口服药用组合物 |
KR101243747B1 (ko) | 2010-07-08 | 2013-03-13 | 주식회사 네비팜 | 고함량 리세드론산 함유 골다공증 치료용 약학조성물 |
KR20120005228A (ko) | 2010-07-08 | 2012-01-16 | 주식회사 네비팜 | 골다공증 치료용 비스포스폰산 함유 장용 약학조성물 및 그의 제조방법 |
KR101156054B1 (ko) | 2011-09-05 | 2012-06-20 | 주식회사 네비팜 | 안정한 에페리손 함유 서방성 의약조성물 |
KR101278572B1 (ko) | 2011-10-18 | 2013-06-25 | 주식회사 네비팜 | 류코트리엔 길항제와 에피나스틴의 복합제제 |
WO2013058527A2 (ko) | 2011-10-18 | 2013-04-25 | 주식회사 네비팜 | 류코트리엔 길항제와 에피나스틴의 복합제제 |
-
2010
- 2010-06-10 KR KR1020100054921A patent/KR101230178B1/ko active Protection Beyond IP Right Term
-
2011
- 2011-06-03 WO PCT/KR2011/004067 patent/WO2011155728A2/ko active Application Filing
- 2011-06-03 JP JP2013514106A patent/JP5756172B2/ja active Active
- 2011-06-03 BR BR112012030485A patent/BR112012030485A2/pt not_active Application Discontinuation
- 2011-06-03 MX MX2012014402A patent/MX360235B/es active IP Right Grant
- 2011-06-03 EP EP11792639.4A patent/EP2581086A4/en not_active Withdrawn
- 2011-06-03 CA CA2798368A patent/CA2798368C/en active Active
- 2011-06-03 US US13/698,619 patent/US9044401B2/en active Active
- 2011-06-03 CN CN201180028606.0A patent/CN102946884B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
JP5756172B2 (ja) | 2015-07-29 |
KR20110135168A (ko) | 2011-12-16 |
US9044401B2 (en) | 2015-06-02 |
BR112012030485A2 (pt) | 2016-08-09 |
WO2011155728A3 (ko) | 2012-05-03 |
CA2798368C (en) | 2015-01-20 |
JP2013528210A (ja) | 2013-07-08 |
MX2012014402A (es) | 2013-02-01 |
EP2581086A4 (en) | 2014-08-06 |
CN102946884B (zh) | 2016-03-16 |
EP2581086A2 (en) | 2013-04-17 |
KR101230178B1 (ko) | 2013-02-06 |
CN102946884A (zh) | 2013-02-27 |
US20130096091A1 (en) | 2013-04-18 |
WO2011155728A2 (ko) | 2011-12-15 |
CA2798368A1 (en) | 2011-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013008737A (es) | Formas de dosificacion oral para tasocitinib que comprende liberacion modificada. | |
MX2013008850A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
AP2012006135A0 (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof. | |
MX2014004122A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas. | |
MY165826A (en) | Pharmaceutical composition | |
WO2013055689A8 (en) | R(+)-n-methyl-propargyl-aminoindan | |
MY149028A (en) | Nalmefene hydrochloride dihydrate | |
ZA201301463B (en) | Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same | |
MX2014004196A (es) | Citramida de rasagilina. | |
MX360235B (es) | Composicion para evitar o tratar osteoporosis y metodo de manufactura para el mismo. | |
WO2012162439A3 (en) | Compositions comprising fusidic acid and packages therefor | |
NZ707636A (en) | Ingenol-derived compounds that can be used for treating cancer | |
MD4615B1 (ro) | Formă solidă izolată de monoclorhidrat de anamorelin, compoziţie farmaceutică şi procedeu de fabricare a formei de dozare farmaceutice care o conţine | |
WO2012155226A8 (pt) | Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos | |
MX2011006721A (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
EP2634183B8 (en) | Method for preparing 1,3,5-trioxane | |
EP2568990A4 (en) | METHOD OF PRODUCING PLEURODESIS | |
GEP201706614B (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process | |
WO2012108631A3 (en) | Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof | |
IN2012DE00826A (es) | ||
EP2634182B8 (en) | Method for preparing 1,3,5-trioxane | |
IN2013MU03428A (es) | ||
GEP20156363B (en) | Composition comprising shellac and/or a salt thereof and sodium starch glycolate | |
IN2014DN07897A (es) | ||
IN2013MU03427A (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: NAVIPHARM CO, LTD.* |
|
FG | Grant or registration |